Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -465,892 | -406,476 | -299,512 | -147,541 | -373,630 |
| Depreciation Amortization | 2,785 | 1,882 | 1,562 | 823 | 2,941 |
| Accounts receivable | -53,822 | -30,463 | -6,899 | 0 | N/A |
| Accounts payable and accrued liabilities | 15,558 | 17,925 | -19,047 | -11,513 | 4,210 |
| Other Working Capital | -72,345 | -8,696 | -30,458 | -22,341 | -3,276 |
| Other Operating Activity | 118,144 | 74,742 | 70,252 | 31,415 | 45,525 |
| Operating Cash Flow | $-455,572 | $-351,086 | $-284,102 | $-149,157 | $-324,230 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -267,924 | -220,169 | -18,557 | 98,410 | -501,041 |
| PPE Investments | -1,462 | -1,267 | -488 | -357 | -1,479 |
| Purchase Sale Intangibles | -5,000 | -5,000 | -5,000 | 0 | N/A |
| Other Investing Activity | -5,000 | -5,000 | -5,000 | 0 | 0 |
| Investing Cash Flow | $-274,386 | $-226,436 | $-24,045 | $98,053 | $-502,520 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 65,000 |
| Common Stock Issued | 735,062 | 715,291 | 707,829 | 573,706 | 530,479 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -363 |
| Financing Cash Flow | $735,062 | $715,291 | $707,829 | $573,706 | $595,116 |
| Beginning Cash Position | 99,915 | 99,915 | 99,915 | 99,915 | 331,549 |
| End Cash Position | 105,019 | 237,684 | 499,597 | 622,517 | 99,915 |
| Net Cash Flow | $5,104 | $137,769 | $399,682 | $522,602 | $-231,634 |
| Free Cash Flow | |||||
| Operating Cash Flow | -455,572 | -351,086 | -284,102 | -149,157 | -324,230 |
| Capital Expenditure | -1,462 | -1,267 | -488 | -357 | -1,479 |
| Free Cash Flow | -457,034 | -352,353 | -284,590 | -149,514 | -325,709 |